APO Research
Talk to an analyst

APO RESEARCH · REPORT

mRNA Vaccines & Therapeutics

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Selected research

Market Analysis & Forecast

Global mRNA Vaccines & Therapeutics Market Analysis and Forecast 2026-2032

28 December 2025193 pages

Choose your research edition.

Industry ResearchmRNA Vaccines & Therapeutics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA Vaccines & Therapeutics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal mRNA Vaccines & Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA Vaccines & Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA Vaccines & Therapeutics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.

This report presents an overview of global market for mRNA Vaccines & Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of mRNA Vaccines & Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for mRNA Vaccines & Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the mRNA Vaccines & Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global mRNA Vaccines & Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for mRNA Vaccines & Therapeutics sales, projected growth trends, production technology, application and end-user industry.

mRNA Vaccines & Therapeutics Segment by Company

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

mRNA Vaccines & Therapeutics Segment by Type

Infectious Disease Vaccines

Cancer Vaccines

mRNA Vaccines & Therapeutics Segment by Application

Infectious Disease

Cancer

mRNA Vaccines & Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of mRNA Vaccines & Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccines & Therapeutics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Infectious Disease Vaccines Major Manufacturers Table 3. Cancer Vaccines Major Manufacturers Table 4. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Infectious Disease Major Manufacturers Table 6. Cancer Major Manufacturers Table 7. mRNA Vaccines & Therapeutics Industry Trends Table 8. mRNA Vaccines & Therapeutics Industry Drivers Table 9. mRNA Vaccines & Therapeutics Industry Opportunities and Challenges Table 10. mRNA Vaccines & Therapeutics Industry Restraints Table 11. Global mRNA Vaccines & Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global mRNA Vaccines & Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 13. Global mRNA Vaccines & Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 14. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2021-2026) Table 15. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2027-2032) Table 16. Global mRNA Vaccines & Therapeutics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global mRNA Vaccines & Therapeutics Sales by Region (2021-2026) & (M Doses) Table 18. Global mRNA Vaccines & Therapeutics Sales by Region (2027-2032) & (M Doses) Table 19. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2026) Table 20. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2027-2032) Table 21. Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 23. Global mRNA Vaccines & Therapeutics Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2021-2026) Table 25. Global mRNA Vaccines & Therapeutics Sales Price (USD/Doses) of Manufacturers (2021-2026) Table 26. Global mRNA Vaccines & Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global mRNA Vaccines & Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global mRNA Vaccines & Therapeutics Manufacturers, Product Type & Application Table 29. Global mRNA Vaccines & Therapeutics Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global mRNA Vaccines & Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global mRNA Vaccines & Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 34. Global mRNA Vaccines & Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 35. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2021-2026) Table 36. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2027-2032) Table 37. Global mRNA Vaccines & Therapeutics Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 38. Global mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 39. Global mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses) Table 40. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026) Table 41. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032) Table 42. Global mRNA Vaccines & Therapeutics Price by Type (2021-2026) & (USD/Doses) Table 43. Global mRNA Vaccines & Therapeutics Price by Type (2027-2032) & (USD/Doses) Table 44. Global mRNA Vaccines & Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 46. Global mRNA Vaccines & Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 47. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2021-2026) Table 48. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2027-2032) Table 49. Global mRNA Vaccines & Therapeutics Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 50. Global mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 51. Global mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses) Table 52. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026) Table 53. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032) Table 54. Global mRNA Vaccines & Therapeutics Price by Application (2021-2026) & (USD/Doses) Table 55. Global mRNA Vaccines & Therapeutics Price by Application (2027-2032) & (USD/Doses) Table 56. Moderna Therapeutics Company Information Table 57. Moderna Therapeutics Business Overview Table 58. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 59. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio Table 60. Moderna Therapeutics Recent Development Table 61. CureVac Company Information Table 62. CureVac Business Overview Table 63. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 64. CureVac mRNA Vaccines & Therapeutics Product Portfolio Table 65. CureVac Recent Development Table 66. Translate Bio Company Information Table 67. Translate Bio Business Overview Table 68. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 69. Translate Bio mRNA Vaccines & Therapeutics Product Portfolio Table 70. Translate Bio Recent Development Table 71. BioNTech Company Information Table 72. BioNTech Business Overview Table 73. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 74. BioNTech mRNA Vaccines & Therapeutics Product Portfolio Table 75. BioNTech Recent Development Table 76. Sangamo Therapeutics Company Information Table 77. Sangamo Therapeutics Business Overview Table 78. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 79. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio Table 80. Sangamo Therapeutics Recent Development Table 81. Argos Therapeutics Company Information Table 82. Argos Therapeutics Business Overview Table 83. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 84. Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio Table 85. Argos Therapeutics Recent Development Table 86. In-Cell-Art Company Information Table 87. In-Cell-Art Business Overview Table 88. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 89. In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio Table 90. In-Cell-Art Recent Development Table 91. eTheRNA Company Information Table 92. eTheRNA Business Overview Table 93. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 94. eTheRNA mRNA Vaccines & Therapeutics Product Portfolio Table 95. eTheRNA Recent Development Table 96. Ethris Company Information Table 97. Ethris Business Overview Table 98. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 99. Ethris mRNA Vaccines & Therapeutics Product Portfolio Table 100. Ethris Recent Development Table 101. Tiba Biotechnology Company Information Table 102. Tiba Biotechnology Business Overview Table 103. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 104. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio Table 105. Tiba Biotechnology Recent Development Table 106. North America mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 107. North America mRNA Vaccines & Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 108. North America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 109. North America mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses) Table 110. North America mRNA Vaccines & Therapeutics Sales Price by Type (2021-2026) & (USD/Doses) Table 111. North America mRNA Vaccines & Therapeutics Sales Price by Type (2027-2032) & (USD/Doses) Table 112. North America mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 113. North America mRNA Vaccines & Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 114. North America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 115. North America mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses) Table 116. North America mRNA Vaccines & Therapeutics Sales Price by Application (2021-2026) & (USD/Doses) Table 117. North America mRNA Vaccines & Therapeutics Sales Price by Application (2027-2032) & (USD/Doses) Table 118. North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 122. North America mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 123. North America mRNA Vaccines & Therapeutics Sales by Country (2027-2032) & (M Doses) Table 124. North America mRNA Vaccines & Therapeutics Sales Price by Country (2021-2026) & (USD/Doses) Table 125. North America mRNA Vaccines & Therapeutics Sales Price by Country (2027-2032) & (USD/Doses) Table 126. United States mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 127. Canada mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 128. Mexico mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 129. Europe mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe mRNA Vaccines & Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 132. Europe mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses) Table 133. Europe mRNA Vaccines & Therapeutics Sales Price by Type (2021-2026) & (USD/Doses) Table 134. Europe mRNA Vaccines & Therapeutics Sales Price by Type (2027-2032) & (USD/Doses) Table 135. Europe mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe mRNA Vaccines & Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 138. Europe mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses) Table 139. Europe mRNA Vaccines & Therapeutics Sales Price by Application (2021-2026) & (USD/Doses) Table 140. Europe mRNA Vaccines & Therapeutics Sales Price by Application (2027-2032) & (USD/Doses) Table 141. Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 145. Europe mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 146. Europe mRNA Vaccines & Therapeutics Sales by Country (2027-2032) & (M Doses) Table 147. Europe mRNA Vaccines & Therapeutics Sales Price by Country (2021-2026) & (USD/Doses) Table 148. Europe mRNA Vaccines & Therapeutics Sales Price by Country (2027-2032) & (USD/Doses) Table 149. Germany mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 150. France mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 151. U.K. mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 152. Italy mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 153. Russia mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 154. Spain mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 155. Netherlands mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 156. Switzerland mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 157. Sweden mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 158. Poland mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 159. China mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 160. China mRNA Vaccines & Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 161. China mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 162. China mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses) Table 163. China mRNA Vaccines & Therapeutics Sales Price by Type (2021-2026) & (USD/Doses) Table 164. China mRNA Vaccines & Therapeutics Sales Price by Type (2027-2032) & (USD/Doses) Table 165. China mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 166. China mRNA Vaccines & Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 167. China mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 168. China mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses) Table 169. China mRNA Vaccines & Therapeutics Sales Price by Application (2021-2026) & (USD/Doses) Table 170. China mRNA Vaccines & Therapeutics Sales Price by Application (2027-2032) & (USD/Doses) Table 171. Asia mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia mRNA Vaccines & Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 174. Asia mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses) Table 175. Asia mRNA Vaccines & Therapeutics Sales Price by Type (2021-2026) & (USD/Doses) Table 176. Asia mRNA Vaccines & Therapeutics Sales Price by Type (2027-2032) & (USD/Doses) Table 177. Asia mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia mRNA Vaccines & Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 180. Asia mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses) Table 181. Asia mRNA Vaccines & Therapeutics Sales Price by Application (2021-2026) & (USD/Doses) Table 182. Asia mRNA Vaccines & Therapeutics Sales Price by Application (2027-2032) & (USD/Doses) Table 183. Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 187. Asia mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 188. Asia mRNA Vaccines & Therapeutics Sales by Country (2027-2032) & (M Doses) Table 189. Asia mRNA Vaccines & Therapeutics Sales Price by Country (2021-2026) & (USD/Doses) Table 190. Asia mRNA Vaccines & Therapeutics Sales Price by Country (2027-2032) & (USD/Doses) Table 191. Japan mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 192. South Korea mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 193. India mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 194. Australia mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 195. Taiwan mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 197. SAMEA mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA mRNA Vaccines & Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 200. SAMEA mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses) Table 201. SAMEA mRNA Vaccines & Therapeutics Sales Price by Type (2021-2026) & (USD/Doses) Table 202. SAMEA mRNA Vaccines & Therapeutics Sales Price by Type (2027-2032) & (USD/Doses) Table 203. SAMEA mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA mRNA Vaccines & Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 206. SAMEA mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses) Table 207. SAMEA mRNA Vaccines & Therapeutics Sales Price by Application (2021-2026) & (USD/Doses) Table 208. SAMEA mRNA Vaccines & Therapeutics Sales Price by Application (2027-2032) & (USD/Doses) Table 209. SAMEA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 213. SAMEA mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 214. SAMEA mRNA Vaccines & Therapeutics Sales by Country (2027-2032) & (M Doses) Table 215. SAMEA mRNA Vaccines & Therapeutics Sales Price by Country (2021-2026) & (USD/Doses) Table 216. SAMEA mRNA Vaccines & Therapeutics Sales Price by Country (2027-2032) & (USD/Doses) Table 217. Brazil mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 218. Argentina mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 219. Chile mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 220. Colombia mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 221. Peru mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 223. Israel mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 224. UAE mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 225. Turkey mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 226. Iran mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 227. Egypt mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. mRNA Vaccines & Therapeutics Distributors List Table 231. mRNA Vaccines & Therapeutics Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. mRNA Vaccines & Therapeutics Image Figure 2. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global mRNA Vaccines & Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Infectious Disease Vaccines Image Figure 5. Cancer Vaccines Image Figure 6. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global mRNA Vaccines & Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 8. Infectious Disease Image Figure 9. Cancer Image Figure 10. Global mRNA Vaccines & Therapeutics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global mRNA Vaccines & Therapeutics Revenue (2021-2032) & (US$ Million) Figure 12. Global mRNA Vaccines & Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2021-2032) Figure 15. Global mRNA Vaccines & Therapeutics Sales (2021-2032) & (M Doses) Figure 16. Global mRNA Vaccines & Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico mRNA Vaccines & Therapeutics Sales YoY (2021-2032) & (M Doses) Figure 19. Europe mRNA Vaccines & Therapeutics Sales YoY (2021-2032) & (M Doses) Figure 20. China mRNA Vaccines & Therapeutics Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) mRNA Vaccines & Therapeutics Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa mRNA Vaccines & Therapeutics Sales YoY (2021-2032) & (M Doses) Figure 23. Global mRNA Vaccines & Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global mRNA Vaccines & Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global mRNA Vaccines & Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2021-2032) Figure 29. Global mRNA Vaccines & Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global mRNA Vaccines & Therapeutics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2032) Figure 32. Global mRNA Vaccines & Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2021-2032) Figure 35. Global mRNA Vaccines & Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global mRNA Vaccines & Therapeutics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2032) Figure 38. North America mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2032) Figure 39. North America mRNA Vaccines & Therapeutics Sales Share by Type (2021-2032) Figure 40. North America mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2032) Figure 41. North America mRNA Vaccines & Therapeutics Sales Share by Application (2021-2032) Figure 42. North America mRNA Vaccines & Therapeutics Revenue Share by Country (2021-2032) Figure 43. North America mRNA Vaccines & Therapeutics Sales Share by Country (2021-2032) Figure 44. Europe mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2032) Figure 45. Europe mRNA Vaccines & Therapeutics Sales Share by Type (2021-2032) Figure 46. Europe mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2032) Figure 47. Europe mRNA Vaccines & Therapeutics Sales Share by Application (2021-2032) Figure 48. Europe mRNA Vaccines & Therapeutics Revenue Share by Country (2021-2032) Figure 49. Europe mRNA Vaccines & Therapeutics Sales Share by Country (2021-2032) Figure 50. China mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2032) Figure 51. China mRNA Vaccines & Therapeutics Sales Share by Type (2021-2032) Figure 52. China mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2032) Figure 53. China mRNA Vaccines & Therapeutics Sales Share by Application (2021-2032) Figure 54. Asia mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2032) Figure 55. Asia mRNA Vaccines & Therapeutics Sales Share by Type (2021-2032) Figure 56. Asia mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2032) Figure 57. Asia mRNA Vaccines & Therapeutics Sales Share by Application (2021-2032) Figure 58. Asia mRNA Vaccines & Therapeutics Revenue Share by Country (2021-2032) Figure 59. Asia mRNA Vaccines & Therapeutics Sales Share by Country (2021-2032) Figure 60. SAMEA mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2032) Figure 61. SAMEA mRNA Vaccines & Therapeutics Sales Share by Type (2021-2032) Figure 62. SAMEA mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2032) Figure 63. SAMEA mRNA Vaccines & Therapeutics Sales Share by Application (2021-2032) Figure 64. SAMEA mRNA Vaccines & Therapeutics Revenue Share by Country (2021-2032) Figure 65. SAMEA mRNA Vaccines & Therapeutics Sales Share by Country (2021-2032) Figure 66. mRNA Vaccines & Therapeutics Value Chain Figure 67. Manufacturing Cost Structure Figure 68. mRNA Vaccines & Therapeutics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Infectious Disease Vaccines
  • Cancer Vaccines
Applications
  • Infectious Disease
  • Cancer
Companies covered
  • Moderna Therapeutics
  • CureVac
  • Translate Bio
  • BioNTech
  • Sangamo Therapeutics
  • Argos Therapeutics
  • In-Cell-Art
  • eTheRNA
  • Ethris
  • Tiba Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 mRNA Vaccines & Therapeutics Market by Type
  3. 1.2.1 Global mRNA Vaccines & Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Infectious Disease Vaccines
  5. 1.2.3 Cancer Vaccines
  6. 1.3 mRNA Vaccines & Therapeutics Market by Application
  7. 1.3.1 Global mRNA Vaccines & Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Infectious Disease
  9. 1.3.3 Cancer
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 mRNA Vaccines & Therapeutics Market Dynamics
  1. 2.1 mRNA Vaccines & Therapeutics Industry Trends
  2. 2.2 mRNA Vaccines & Therapeutics Industry Drivers
  3. 2.3 mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
  4. 2.4 mRNA Vaccines & Therapeutics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global mRNA Vaccines & Therapeutics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global mRNA Vaccines & Therapeutics Revenue by Region
  3. 3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global mRNA Vaccines & Therapeutics Revenue by Region (2021-2026)
  5. 3.2.3 Global mRNA Vaccines & Therapeutics Revenue by Region (2027-2032)
  6. 3.2.4 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global mRNA Vaccines & Therapeutics Sales by Region
  9. 3.4.1 Global mRNA Vaccines & Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global mRNA Vaccines & Therapeutics Sales by Region (2021-2026)
  11. 3.4.3 Global mRNA Vaccines & Therapeutics Sales by Region (2027-2032)
  12. 3.4.4 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers
  2. 4.1.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global mRNA Vaccines & Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global mRNA Vaccines & Therapeutics Sales by Manufacturers
  6. 4.2.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global mRNA Vaccines & Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global mRNA Vaccines & Therapeutics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global mRNA Vaccines & Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global mRNA Vaccines & Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global mRNA Vaccines & Therapeutics Manufacturers, Product Type & Application
  13. 4.7 Global mRNA Vaccines & Therapeutics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global mRNA Vaccines & Therapeutics Market CR5 and HHI
  16. 4.8.2 2025 mRNA Vaccines & Therapeutics Tier 1, Tier 2, and Tier 3
5 mRNA Vaccines & Therapeutics Market by Type
  1. 5.1 Global mRNA Vaccines & Therapeutics Revenue by Type
  2. 5.1.1 Global mRNA Vaccines & Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global mRNA Vaccines & Therapeutics Sales by Type
  6. 5.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global mRNA Vaccines & Therapeutics Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2032)
  9. 5.3 Global mRNA Vaccines & Therapeutics Price by Type
6 mRNA Vaccines & Therapeutics Market by Application
  1. 6.1 Global mRNA Vaccines & Therapeutics Revenue by Application
  2. 6.1.1 Global mRNA Vaccines & Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global mRNA Vaccines & Therapeutics Sales by Application
  6. 6.2.1 Global mRNA Vaccines & Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global mRNA Vaccines & Therapeutics Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2032)
  9. 6.3 Global mRNA Vaccines & Therapeutics Price by Application
7 Company Profiles
  1. 7.1 Moderna Therapeutics
  2. 7.1.1 Moderna Therapeutics Company Information
  3. 7.1.2 Moderna Therapeutics Business Overview
  4. 7.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
  6. 7.1.5 Moderna Therapeutics Recent Developments
  7. 7.2 CureVac
  8. 7.2.1 CureVac Company Information
  9. 7.2.2 CureVac Business Overview
  10. 7.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
  12. 7.2.5 CureVac Recent Developments
  13. 7.3 Translate Bio
  14. 7.3.1 Translate Bio Company Information
  15. 7.3.2 Translate Bio Business Overview
  16. 7.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
  18. 7.3.5 Translate Bio Recent Developments
  19. 7.4 BioNTech
  20. 7.4.1 BioNTech Company Information
  21. 7.4.2 BioNTech Business Overview
  22. 7.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
  24. 7.4.5 BioNTech Recent Developments
  25. 7.5 Sangamo Therapeutics
  26. 7.5.1 Sangamo Therapeutics Company Information
  27. 7.5.2 Sangamo Therapeutics Business Overview
  28. 7.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
  30. 7.5.5 Sangamo Therapeutics Recent Developments
  31. 7.6 Argos Therapeutics
  32. 7.6.1 Argos Therapeutics Company Information
  33. 7.6.2 Argos Therapeutics Business Overview
  34. 7.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
  36. 7.6.5 Argos Therapeutics Recent Developments
  37. 7.7 In-Cell-Art
  38. 7.7.1 In-Cell-Art Company Information
  39. 7.7.2 In-Cell-Art Business Overview
  40. 7.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
  42. 7.7.5 In-Cell-Art Recent Developments
  43. 7.8 eTheRNA
  44. 7.8.1 eTheRNA Company Information
  45. 7.8.2 eTheRNA Business Overview
  46. 7.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
  48. 7.8.5 eTheRNA Recent Developments
  49. 7.9 Ethris
  50. 7.9.1 Ethris Company Information
  51. 7.9.2 Ethris Business Overview
  52. 7.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
  54. 7.9.5 Ethris Recent Developments
  55. 7.10 Tiba Biotechnology
  56. 7.10.1 Tiba Biotechnology Company Information
  57. 7.10.2 Tiba Biotechnology Business Overview
  58. 7.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
  60. 7.10.5 Tiba Biotechnology Recent Developments
8 North America
  1. 8.1 North America mRNA Vaccines & Therapeutics Market Size by Type
  2. 8.1.1 North America mRNA Vaccines & Therapeutics Revenue by Type (2021-2032)
  3. 8.1.2 North America mRNA Vaccines & Therapeutics Sales by Type (2021-2032)
  4. 8.1.3 North America mRNA Vaccines & Therapeutics Price by Type (2021-2032)
  5. 8.2 North America mRNA Vaccines & Therapeutics Market Size by Application
  6. 8.2.1 North America mRNA Vaccines & Therapeutics Revenue by Application (2021-2032)
  7. 8.2.2 North America mRNA Vaccines & Therapeutics Sales by Application (2021-2032)
  8. 8.2.3 North America mRNA Vaccines & Therapeutics Price by Application (2021-2032)
  9. 8.3 North America mRNA Vaccines & Therapeutics Market Size by Country
  10. 8.3.1 North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America mRNA Vaccines & Therapeutics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe mRNA Vaccines & Therapeutics Market Size by Type
  2. 9.1.1 Europe mRNA Vaccines & Therapeutics Revenue by Type (2021-2032)
  3. 9.1.2 Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2032)
  4. 9.1.3 Europe mRNA Vaccines & Therapeutics Price by Type (2021-2032)
  5. 9.2 Europe mRNA Vaccines & Therapeutics Market Size by Application
  6. 9.2.1 Europe mRNA Vaccines & Therapeutics Revenue by Application (2021-2032)
  7. 9.2.2 Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2032)
  8. 9.2.3 Europe mRNA Vaccines & Therapeutics Price by Application (2021-2032)
  9. 9.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
  10. 9.3.1 Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe mRNA Vaccines & Therapeutics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China mRNA Vaccines & Therapeutics Market Size by Type
  2. 10.1.1 China mRNA Vaccines & Therapeutics Revenue by Type (2021-2032)
  3. 10.1.2 China mRNA Vaccines & Therapeutics Sales by Type (2021-2032)
  4. 10.1.3 China mRNA Vaccines & Therapeutics Price by Type (2021-2032)
  5. 10.2 China mRNA Vaccines & Therapeutics Market Size by Application
  6. 10.2.1 China mRNA Vaccines & Therapeutics Revenue by Application (2021-2032)
  7. 10.2.2 China mRNA Vaccines & Therapeutics Sales by Application (2021-2032)
  8. 10.2.3 China mRNA Vaccines & Therapeutics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia mRNA Vaccines & Therapeutics Market Size by Type
  2. 11.1.1 Asia mRNA Vaccines & Therapeutics Revenue by Type (2021-2032)
  3. 11.1.2 Asia mRNA Vaccines & Therapeutics Sales by Type (2021-2032)
  4. 11.1.3 Asia mRNA Vaccines & Therapeutics Price by Type (2021-2032)
  5. 11.2 Asia mRNA Vaccines & Therapeutics Market Size by Application
  6. 11.2.1 Asia mRNA Vaccines & Therapeutics Revenue by Application (2021-2032)
  7. 11.2.2 Asia mRNA Vaccines & Therapeutics Sales by Application (2021-2032)
  8. 11.2.3 Asia mRNA Vaccines & Therapeutics Price by Application (2021-2032)
  9. 11.3 Asia mRNA Vaccines & Therapeutics Market Size by Country
  10. 11.3.1 Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia mRNA Vaccines & Therapeutics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA mRNA Vaccines & Therapeutics Market Size by Type
  2. 12.1.1 SAMEA mRNA Vaccines & Therapeutics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA mRNA Vaccines & Therapeutics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA mRNA Vaccines & Therapeutics Price by Type (2021-2032)
  5. 12.2 SAMEA mRNA Vaccines & Therapeutics Market Size by Application
  6. 12.2.1 SAMEA mRNA Vaccines & Therapeutics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA mRNA Vaccines & Therapeutics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA mRNA Vaccines & Therapeutics Price by Application (2021-2032)
  9. 12.3 SAMEA mRNA Vaccines & Therapeutics Market Size by Country
  10. 12.3.1 SAMEA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA mRNA Vaccines & Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA mRNA Vaccines & Therapeutics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 mRNA Vaccines & Therapeutics Value Chain Analysis
  2. 13.1.1 mRNA Vaccines & Therapeutics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 mRNA Vaccines & Therapeutics Production Mode & Process
  6. 13.2 mRNA Vaccines & Therapeutics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 mRNA Vaccines & Therapeutics Distributors
  9. 13.2.3 mRNA Vaccines & Therapeutics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst